SAN

91.13

+1.75%↑

SHL.DE

49.37

+1.94%↑

ARGX

498

+2.91%↑

FRE

42.42

+0.17%↑

ONC.US

225.61

+2.68%↑

SAN

91.13

+1.75%↑

SHL.DE

49.37

+1.94%↑

ARGX

498

+2.91%↑

FRE

42.42

+0.17%↑

ONC.US

225.61

+2.68%↑

SAN

91.13

+1.75%↑

SHL.DE

49.37

+1.94%↑

ARGX

498

+2.91%↑

FRE

42.42

+0.17%↑

ONC.US

225.61

+2.68%↑

SAN

91.13

+1.75%↑

SHL.DE

49.37

+1.94%↑

ARGX

498

+2.91%↑

FRE

42.42

+0.17%↑

ONC.US

225.61

+2.68%↑

SAN

91.13

+1.75%↑

SHL.DE

49.37

+1.94%↑

ARGX

498

+2.91%↑

FRE

42.42

+0.17%↑

ONC.US

225.61

+2.68%↑

Search

Merck KGaA

Cerrado

SectorSanidad

115.85 -6.87

Resumen

Variación precio

24h

Actual

Mínimo

114.6

Máximo

124.2

Métricas clave

By Trading Economics

Ingresos

-142M

667M

Ventas

152M

5.4B

P/B

Media del Sector

26.27

56.602

BPA

2.2

Rentabilidad por dividendo

1.34

Margen de beneficios

12.311

EBITDA

85M

1.6B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+33.05% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.34%

2.45%

Próximas Ganancias

15 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

33B

98B

Apertura anterior

122.72

Cierre anterior

115.85

Noticias sobre sentimiento de mercado

By Acuity

22%

78%

49 / 382 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Merck KGaA Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

28 abr 2025, 11:25 UTC

Adquisiciones, fusiones, absorciones

Germany's Merck to Buy SpringWorks for $3.9 Billion -- Update

28 abr 2025, 06:41 UTC

Adquisiciones, fusiones, absorciones

Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal

6 mar 2025, 06:27 UTC

Ganancias

Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results

28 abr 2025, 15:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Merck KGaA's $3.9B SpringWorks Therapeutics Buy Underwhelms -- Market Talk

28 abr 2025, 09:20 UTC

Acciones populares

Stocks to Watch Monday: DoorDash, Merck, Spirit AeroSystems, Airbus -- WSJ

28 abr 2025, 08:36 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Germany's Merck's Deal to Acquire SpringWorks Makes Strategic Sense, but Price in Focus -- Market Talk

28 abr 2025, 06:06 UTC

Adquisiciones, fusiones, absorciones

Germany's Merck: Acquisition Will Strengthen Merck Healthcare Presence in U.S.

28 abr 2025, 06:05 UTC

Adquisiciones, fusiones, absorciones

Germany's Merck: Planned Acquisition Will Immediately Add Revenue, Accelerate Growth

28 abr 2025, 06:05 UTC

Adquisiciones, fusiones, absorciones

Germany's Merck: Deal Is for Purchase Price of $47 a Share in Cash

28 abr 2025, 06:04 UTC

Adquisiciones, fusiones, absorciones

Germany's Merck to Buy SpringWorks for About $3.9B

28 abr 2025, 06:02 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Germany's Merck to Buy SpringWorks Therapeutics

24 abr 2025, 22:51 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

24 abr 2025, 20:54 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into

24 abr 2025, 20:50 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share

24 abr 2025, 19:05 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ

24 abr 2025, 19:05 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ

24 abr 2025, 19:05 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ

24 abr 2025, 19:05 UTC

Adquisiciones, fusiones, absorciones

Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ

6 mar 2025, 11:18 UTC

Charlas de Mercado
Ganancias

Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk

6 mar 2025, 11:14 UTC

Charlas de Mercado

Merck KGaA's Outlook Signals Greater Transparency -- Market Talk

6 mar 2025, 08:20 UTC

Charlas de Mercado
Ganancias

Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 Adj EPS EUR8.63

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 EBIT EUR3.645B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 After-Tax Profit EUR2.79B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 EBITDA EUR5.78B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA 2024 Sales EUR21.16B

6 mar 2025, 06:00 UTC

Ganancias

Merck KGaA Keeps Dividend at EUR2.20

Comparación entre iguales

Cambio de precio

Merck KGaA previsión

Precio Objetivo

By TipRanks

33.05% repunte

Estimación a 12 Meses

Media 164.78 EUR  33.05%

Máximo 190 EUR

Mínimo 107 EUR

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Merck KGaA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

8

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

121.15 / 123.55Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Neutral Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

49 / 382 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Merck KGaA

There is no Profile data available for MRK.BE.